Methyl 4-(4-aminopiperidine-1-carbonyl)benzoate hydrochloride, 95.0%, 10g

(R)-6-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride, 97%, 50mg

Lorlatinib, 99.92%, 1g

N-Methoxy-N-methyltetrahydro-2H-pyran-4-carboxamide, 95.0%, 25g

5-CYCLOPROPYL-1,2,3-THIADIAZOLE-4-CARBOXYLIC ACID, 95.0%, 2g

(4-(Decyloxy)phenyl)(phenyl)methanone, 98%, 500g

3-(2-(2-(2-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL)AMINO)ETHOXY)ETHOXY)ETHOXY)PROPANOIC ACID, 95%, 25mg

3-Bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine, 95.0%, 250mg

3-tert-Butoxycarbonylaminophenyl acetic acid, 98.0%, 250mg

3-((4-(Methyl(4-(3-(4-(trifluoromethoxy)phenyl)ureido)phenyl)amino)pyrimidin-2-yl)amino)benzenesulfonamide, 98+%, 250mg

(S)-2-(1-Aminoethyl)-4-fluorophenol hydrochloride, 95.0%, 100mg

N,N'-(Ethane-1,2-diyl)bis(4-methylbenzenesulfonamide), 95.0%, 1g

(4R)-4-Amino-3,3-dimethylpyrrolidin-2-one, 97%, 5g